Literature DB >> 15546718

Synthesis of 8-thiabicyclo[3.2.1]oct-2-enes and their binding affinity for the dopamine and serotonin transporters.

Peter C Meltzer1, Duy-Phong Pham-Huu, Bertha K Madras.   

Abstract

The reinforcing and stimulant properties of cocaine have been primarily associated with its propensity to bind to monoamine transport systems, in particular the dopamine transporter. Inhibition of the dopamine transporter then leads to an increase of synaptic dopamine with substantial pharmacological consequences. The search for medications for cocaine abuse has had a particular focus on tropane analogs of cocaine, and the interchange of nitrogen for oxygen in this class has led to potent and selective inhibitors of monoamine transport. Herein we report that 8-thiatrop-2-enes are highly potent and quite selective inhibitors of the dopamine transporter. The 3,4-dichlorophenyl-8-thiabicyclo[3.2.1]oct-2-ene (4f) is particularly potent (IC50=4.5 nM) and selective (800-fold) with respect to inhibition of the serotonin transporter.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15546718     DOI: 10.1016/j.bmcl.2004.09.080

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Synthesis and structure-activity relationship studies of 3-biaryl-8-oxabicyclo[3.2.1]octane-2-carboxylic acid methyl esters.

Authors:  Lokman Torun; Bertha K Madras; Peter C Meltzer
Journal:  Bioorg Med Chem       Date:  2012-02-08       Impact factor: 3.641

2.  The synthesis and biological evaluation of 2-(3-methyl or 3-phenylisoxazol-5-yl)-3-aryl-8-thiabicyclo[3.2.1]octanes.

Authors:  Madhusudhan Purushotham; Anjaneyulu Sheri; Duy-Phong Pham-Huu; Bertha K Madras; Aaron Janowsky; Peter C Meltzer
Journal:  Bioorg Med Chem Lett       Date:  2010-11-21       Impact factor: 2.823

3.  Synthesis of 8-thiabicyclo[3.2.1]octanes and their binding affinity for the dopamine and serotonin transporters.

Authors:  Duy-Phong Pham-Huu; Jeffrey R Deschamps; Shanghao Liu; Bertha K Madras; Peter C Meltzer
Journal:  Bioorg Med Chem       Date:  2006-10-27       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.